drugset

drugset / Trial / NCT00567372

POSTERIOR SUB-TENON'S Avastin

NCT00567372 ↗

Phase 4 Withdrawn Asociación para Evitar la Ceguera en México

NaSingle-groupOpen-labelTreatment

Summary

Posterior sub-tenon's injection of bevacizumab decreased diffuse diabetic macular edema

Timeline

Start: 2008-06
Primary completion: 2008-11
Completion: 2009-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bevacizumab	Monoclonal antibody	2.5 mg	Other

Indications